2,4-diaminoquinazoline has been researched along with Hepatitis C in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, PL; Hu, YH; Jing, JF; Li, YC; Tang, W; Tong, XK; Yu, Y; Zuo, JP | 1 |
1 other study(ies) available for 2,4-diaminoquinazoline and Hepatitis C
| Article | Year |
|---|---|
Discovering novel anti-HCV compounds with inhibitory activities toward HCV NS3/4A protease.
Topics: Amides; Antiviral Agents; Cell Line; Drug Evaluation, Preclinical; Hepacivirus; Hepatitis C; Humans; Quinazolines; Viral Nonstructural Proteins | 2014 |